Literature DB >> 15189184

A probable cause of paradoxical thrombosis in zygomycosis.

R Rüchel1, C Elsner, A Spreer.   

Abstract

Invasive zygomycoses (syn. mucormycoses) are rather rare but life-threatening diseases which often take a peracute course. Particularly endangered are diabetics and patients suffering from siderophilia. Zygomycosis is regularly complicated by thrombosis and subsequent necrosis. Usually it evolves from sinusitis in a rhinocerebral form. With the use of a clinical isolate (Rhizopus microsporus) and sera of the same female survivor, we investigated possible sources of the typical blood clotting. The results suggest that coagulation is probably initiated in a bimodal manner by an extracellular serine proteinase of the fungus and by elastase from the patients' leukocytes. The former causes a partial hydrolysis of fibrinogen, while the latter activates coagulation factor XIII (fibrin stabilizing factor). Both proteinases were present in the patient at the site of infection, and in vitro they jointly bring about regular clotting of fibrinogen.

Entities:  

Mesh:

Year:  2004        PMID: 15189184     DOI: 10.1111/j.1439-0507.2004.00981.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  4 in total

Review 1.  [Differential diagnosis for detection of hyphae in tissue].

Authors:  K Tintelnot
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

Review 2.  Fungal infections in burns: a comprehensive review.

Authors:  M F Struck; J Gille
Journal:  Ann Burns Fire Disasters       Date:  2013-09-30

3.  Outstanding personalities in German-speaking mycology : Dedicated to Professor Dr. Johannes Müller.

Authors:  Claus Seebacher; Torello Lotti; Maria Grazia Roccia; Massimo Fioranelli; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2017-02-23

4.  Concurrent cranial mediastinal Blastomyces granuloma and carcinoma with cranial vena caval syndrome in a dog.

Authors:  Natashia A Evans; Katrina R Viviano
Journal:  Can Vet J       Date:  2015-11       Impact factor: 1.008

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.